Migrabeta-TR 20 Tablet SR
Marketer
Alkem Laboratories Ltd
Salt Composition
Propranolol (20mg)
Overview Migrabeta-TR 20 Tablet SR
Propranolol extended-release 20mg tablets alleviate anxiety and tremors. This medication also prevents migraines, angina (chest pain from heart conditions), and gastrointestinal bleeding stemming from portal hypertension (high blood pressure in the liver). It further treats hypertension (high blood pressure) and certain arrhythmias (irregular heartbeats). Dosage varies depending on the condition and individual response; always follow your physician's instructions. Administer on an empty stomach at approximately the same time daily. Continue taking the medication even if symptoms improve, as ongoing benefits persist. Sudden cessation may exacerbate your condition. Common side effects include fatigue, weakness, Raynaud's phenomenon (cold extremities), bradycardia (slow heartbeat), paresthesia (numbness in fingers), and dyspnea (shortness of breath). Nausea, vomiting, and diarrhea may also occur. Consult your doctor if side effects are troublesome or persistent; most are transient and diminish with continued use. Avoid this medication if you have asthma, severe bradycardia, or significant heart disease including heart failure. Individuals with kidney or liver impairment or COPD should discuss use with their doctor beforehand. Alcohol consumption can interfere with efficacy and should be avoided. Refrain from driving if dizziness occurs. Consult your doctor regarding the safety of this medicine during pregnancy or breastfeeding.
Uses of Migrabeta-TR 20 Tablet SR
Managing angina pectoris (chest pain of cardiac origin) | Correcting cardiac arrhythmias | Reducing the risk of myocardial infarction | Controlling hypertension (elevated blood pressure) | Addressing anxiety disorders | Managing tremors | Preventing migraine headaches | Treating pheochromocytoma
Major Benefits of Migrabeta-TR 20 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Migrabeta-TR 20 Tablet SR whole; do not crush, chew, or break it. Administer this medication on an empty stomach. Consumption of Migrabeta-TR 20 Tablet SR should avoid concurrent ingestion of high-fat foods including, but not limited to, olive oil, nuts (especially Brazil nuts), dark chocolate, butter, and red meat.
Common Side effects of Migrabeta-TR 20 Tablet SR:
- Cold extremities
- Sleep disturbance
- Fatigue
- Slow heart rate
- Nightmares
How to use Migrabeta-TR 20 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Migrabeta-TR 20 Tablet SR. Ingest the tablet whole; do not crush, chew, or break it. Administer this medication on an empty stomach. Consuming Migrabeta-TR 20 Tablet SR with high-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and meat, should be avoided.
How Migrabeta-TR 20 Tablet SR works:
Migrabeta-TR 20 SR tablets utilize propranolol, a beta-adrenergic blocking agent, to modulate the body's neurological responses, particularly within the cardiovascular system. This action reduces heart rate and improves cardiac output, thereby mitigating arrhythmias. Simultaneously, it promotes vasodilation, enhancing circulation and alleviating both angina and migraine symptoms. The precise mechanism by which it reduces tremors remains unclear; however, it's hypothesized that the drug interferes with nerve signals to tremor-inducing muscles. Propranolol counteracts the effects of adrenaline and noradrenaline, neurotransmitters that elevate heart rate and anxiety levels, thus providing anxiolytic benefits. In pheochromocytoma treatment, Migrabeta-TR 20 SR helps manage excessive adrenaline, mitigating the risk of dangerously elevated blood pressure during tumor resection.
SAFETY ADVICE
AlcoholUNSAFE
Combining Migrabeta-TR 20 Tablet SR and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The extended-release Migrabeta-TR 20mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
Sustained-release Migrabeta-TR 20mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer via breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with severe kidney impairment should use Migrabeta-TR 20 Tablet SR cautiously. A modified dosage of Migrabeta-TR 20 Tablet SR might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Migrabeta-TR 20 Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Migrabeta-TR 20 Tablet SR :
Should you forget a Migrabeta-TR 20 Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Migrabeta-TR 20 Tablet SR
| Label | Value |
|---|---|
| Chemical Classification | Naphthalene derivatives |
| Developing Habits | No. |
| Treatment Category | Heart |






